The expression levels of MYBL2 were positively correlated with those of E2F1 in hepatocellular carcinomas, and downregulation of E2F1 in hepatocellular carcinoma cells reduced MYBL2 expression (42). This evidence concerns the gene E2F1 and hepatocellular carcinoma.